CRP and cancer: Recently, inflammatory biomarkers, such as C-reactive protein (CRP), the neutrophil-to-lymphocyte ratio (NLR), the monocyte-to-lymphocyte ratio (MLR), and the platelet-to-lymphocyte ratio (PLR) were found to be associated with cancer prognosis [33].